Articles
Page 9 of 20
-
Citation: BMC Pharmacology 2009 9(Suppl 1):P80
-
Effect of exercise training on endothelium-dependent relaxing response and cGMP concentration in pulmonary artery from rats submitted to lung ischemia/reperfusion
Citation: BMC Pharmacology 2009 9(Suppl 1):P77 -
Possible identification of novel natriuretic peptide receptor phosphorylation sites by alanine/glutamate mutagenesis
Citation: BMC Pharmacology 2009 9(Suppl 1):P76 -
Therapeutic potential of CNP for skeletal dysplasias
Citation: BMC Pharmacology 2009 9(Suppl 1):P74 -
Role of the general base Glu268 in nitroglycerin bioactivation and mechanism-based superoxide formation by aldehyde dehydrogenase-2
Citation: BMC Pharmacology 2009 9(Suppl 1):P72 -
Is kynurenine a novel and important vasodilator in human septic shock?
Citation: BMC Pharmacology 2009 9(Suppl 1):P70 -
Blockade of CNG channels abrogates urethral relaxation induced by soluble guanylate cyclase activation
Citation: BMC Pharmacology 2009 9(Suppl 1):P69 -
Mechanisms of relaxant activity of BAY 41-2272 in rat tracheal smooth muscle in vitro
Citation: BMC Pharmacology 2009 9(Suppl 1):P68 -
Sensitive assay for the detection of cyclic nucleotides by mass spectrometry
Citation: BMC Pharmacology 2009 9(Suppl 1):P66 -
NO/cGMP signalling in platelets
Citation: BMC Pharmacology 2009 9(Suppl 1):P62 -
NO inhibits platelet apoptosis by cGMP-dependent and-independent pathways
Citation: BMC Pharmacology 2009 9(Suppl 1):P60 -
Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
Citation: BMC Pharmacology 2009 9(Suppl 1):P56 -
Effect of L-carnitine supplementation on the sGC/cGMP pathway in vascular relaxing responses from exercised rats
Citation: BMC Pharmacology 2009 9(Suppl 1):P54 -
Acute hemodynamic response to single oral doses of BAY 60-4552, a soluble guanylate cyclase stimulator, in patients with biventricular heart failure
Citation: BMC Pharmacology 2009 9(Suppl 1):P51 -
Receptor guanylyl cyclases in mammalian olfaction: from genes to function
Citation: BMC Pharmacology 2009 9(Suppl 1):S45 -
Cross-talk of inhibitory and stimulatory signalling pathways of human platelets
Citation: BMC Pharmacology 2009 9(Suppl 1):S43 -
Phosphodiesterase-5 inhibition delays cardiac dilation and improves myocardial function in a rat model of heart failure due to chronic volume overload
Citation: BMC Pharmacology 2009 9(Suppl 1):P41 -
Cyclic GMP signalling in human ES and iPS-derived vascular cells
Citation: BMC Pharmacology 2009 9(Suppl 1):S40 -
Kynurenine is a novel endothelium-derived vascular relaxing factor produced during inflammation
Citation: BMC Pharmacology 2009 9(Suppl 1):S39 -
Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs
Citation: BMC Pharmacology 2009 9(Suppl 1):P37 -
Pharmacological activation of soluble guanylate cyclase activator protects the heart against isoproterenol-induced myocardial ischemia in rats
Citation: BMC Pharmacology 2009 9(Suppl 1):P35 -
The PKG1 specific phosphorylation substrate cysteine-rich protein 2 knockout decreases blood pressure and intimal hyperplasia
Citation: BMC Pharmacology 2009 9(Suppl 1):S33 -
C-type natriuretic peptide is a Schwann cell-derived factor for development and function of sensory neurons
Citation: BMC Pharmacology 2009 9(Suppl 1):P33 -
Janus-faced signaling of cGMP in acute lung injury
Citation: BMC Pharmacology 2009 9(Suppl 1):S31 -
Nitroxyl, the novel redox sibling of NO, suppresses cerebrovascular NADPH oxidase
Citation: BMC Pharmacology 2009 9(Suppl 1):P31 -
Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension
Citation: BMC Pharmacology 2009 9(Suppl 1):P29 -
A novel designer natriuretic peptide CD-NP suppresses TGF-beta 1 induced collagen Type I production in human cardiac fibroblasts
Citation: BMC Pharmacology 2009 9(Suppl 1):P27 -
Subcellular distribution of cGMP signalling proteins in VSMCs of IRAG KO mice
Citation: BMC Pharmacology 2009 9(Suppl 1):P25 -
Phosphodiesterase-5 inhibition and cardioprotection: potential role of hydrogen sulfide
Citation: BMC Pharmacology 2009 9(Suppl 1):S24 -
The natriuretic peptide/guanylyl cyclase-A system functions as a stress-responsive regulator of angiogenesis in mice
Citation: BMC Pharmacology 2009 9(Suppl 1):S23 -
Crosstalk of cyclic GMP dependent kinase I and BMP signaling
Citation: BMC Pharmacology 2009 9(Suppl 1):P23 -
A splice variant of the guanylyl cyclase-A receptor interferes with atrial natriuretic peptide (ANP) signaling
Citation: BMC Pharmacology 2009 9(Suppl 1):P22 -
Yin and Yang of cGMP signalling in hydrostatic lung edema
Citation: BMC Pharmacology 2009 9(Suppl 1):S22 -
Direct evidence for close proximity of catalytic and regulatory domains of heterodimeric sGC based on fluorescence resonance energy transfer
Citation: BMC Pharmacology 2009 9(Suppl 1):P21 -
Cyclic GMP-dependent protein kinase II promotes chondrocyte hypertrophy and skeletal growth
Citation: BMC Pharmacology 2009 9(Suppl 1):S20 -
Blood pressure-independent effects of enhanced NO/cGMP signalling and gender on aortic remodelling in experimental renal hypertension
Citation: BMC Pharmacology 2009 9(Suppl 1):P19 -
Novel mechanisms of anti-hypertrophic effects from PDE5A inhibition
Citation: BMC Pharmacology 2009 9(Suppl 1):S18 -
Bioactivation of pentaerythrityl tetranitrate by mitochondrial aldehyde dehydrogenase
Citation: BMC Pharmacology 2009 9(Suppl 1):P17 -
Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
Citation: BMC Pharmacology 2009 9(Suppl 1):P15 -
Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
Citation: BMC Pharmacology 2009 9(Suppl 1):S14 -
NO signalling in mice lacking the NO receptor guanylyl cyclase
Citation: BMC Pharmacology 2009 9(Suppl 1):S12 -
Molecular mechanisms underlying pharmacological stimulation of eNOS expression and eNOS activity
Citation: BMC Pharmacology 2009 9(Suppl 1):S11 -
Redox regulation of protein kinase G
Citation: BMC Pharmacology 2009 9(Suppl 1):S10 -
Modulating cGMP in heart failure by novel natriuretic peptides
Citation: BMC Pharmacology 2009 9(Suppl 1):S8 -
Renal targeted protein therapeutics in experimental overt heart failure with renal dysfunction
Citation: BMC Pharmacology 2009 9(Suppl 1):P7 -
Phenotypes of sGC mutant mice in basic conditions, disease and shock
Citation: BMC Pharmacology 2009 9(Suppl 1):S6 -
sGCα1β1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models
Citation: BMC Pharmacology 2009 9(Suppl 1):P5 -
B-type natriuretic peptide single nucleotide polymorphism rs198389 and survival in the general community
Citation: BMC Pharmacology 2009 9(Suppl 1):P4 -
Thiol-dependent redox modulation of soluble guanylyl cyclase
Citation: BMC Pharmacology 2009 9(Suppl 1):S4 -
Bioactivation of nitroglycerin by the East Asian variant of aldehyde dehydrogenase-2
Citation: BMC Pharmacology 2009 9(Suppl 1):P3